Catalyst Wire Dossier Catalyst Wire Dossier

Lenalidomide

lenalidomide · Novugen Pharma (USA) LLC
Drug timelines are a Plus or Pro feature.

520 regulatory and trial events tracked for Lenalidomide, covering 2006-12-20 to 2026-08-13. Get the full timeline:

Most recent: Clinical Trial Results: Brentuximab Vedotin and Lenalidomide in Treating Patients With Stage IB-IVB Relapsed or Refractory T-Cell Lymphoma [Phase 2]

See pricing